XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance (in shares) at Dec. 31, 2023   21,080,472    
Balance at Dec. 31, 2023 $ 53,921 $ 2 $ 191,569 $ (137,650)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   96,116    
Exercise of stock options 353   353  
Issuance of common stock under stock incentive plans (in shares)   229,923    
Stock-based compensation expense 1,714   1,714  
Net (loss) income (202)     (202)
Balance (in shares) at Mar. 31, 2024   21,406,511    
Balance at Mar. 31, 2024 55,786 $ 2 193,636 (137,852)
Balance (in shares) at Dec. 31, 2023   21,080,472    
Balance at Dec. 31, 2023 53,921 $ 2 191,569 (137,650)
Increase (Decrease) in Stockholders' Equity        
Net (loss) income (433)      
Balance (in shares) at Sep. 30, 2024   21,833,041    
Balance at Sep. 30, 2024 59,274 $ 2 197,355 (138,083)
Balance (in shares) at Mar. 31, 2024   21,406,511    
Balance at Mar. 31, 2024 55,786 $ 2 193,636 (137,852)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   9,549    
Exercise of stock options 35   35  
Issuance of common stock under stock incentive plans (in shares)   240,623    
Issuance of common stock under stock incentive plans 241   241  
Stock-based compensation expense 1,862   1,862  
Net (loss) income (2,502)     (2,502)
Balance (in shares) at Jun. 30, 2024   21,656,683    
Balance at Jun. 30, 2024 55,422 $ 2 195,774 (140,354)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   11,177    
Exercise of stock options 44   44  
Issuance of common stock under stock incentive plans (in shares)   165,181    
Issuance of common stock under stock incentive plans 5   5  
Stock-based compensation expense 1,532   1,532  
Net (loss) income 2,271     2,271
Balance (in shares) at Sep. 30, 2024   21,833,041    
Balance at Sep. 30, 2024 59,274 $ 2 197,355 (138,083)
Balance (in shares) at Dec. 31, 2024   22,059,697    
Balance at Dec. 31, 2024 62,593 $ 2 199,460 (136,869)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   10,620    
Exercise of stock options 29   29  
Issuance of common stock under stock incentive plans (in shares)   281,828    
Stock-based compensation expense 1,577   1,577  
Net (loss) income (1,166)     (1,166)
Balance (in shares) at Mar. 31, 2025   22,352,145    
Balance at Mar. 31, 2025 63,033 $ 2 201,066 (138,035)
Balance (in shares) at Dec. 31, 2024   22,059,697    
Balance at Dec. 31, 2024 $ 62,593 $ 2 199,460 (136,869)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares) 82,823      
Net (loss) income $ (1,782)      
Balance (in shares) at Sep. 30, 2025   22,756,779    
Balance at Sep. 30, 2025 65,821 $ 2 204,470 (138,651)
Balance (in shares) at Mar. 31, 2025   22,352,145    
Balance at Mar. 31, 2025 63,033 $ 2 201,066 (138,035)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   12,733    
Exercise of stock options 39   39  
Issuance of common stock under stock incentive plans (in shares)   205,713    
Issuance of common stock under stock incentive plans 254   254  
Stock-based compensation expense 1,419   1,419  
Net (loss) income (670)     (670)
Balance (in shares) at Jun. 30, 2025   22,570,591    
Balance at Jun. 30, 2025 64,075 $ 2 202,778 (138,705)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   59,470    
Exercise of stock options 285   285  
Issuance of common stock under stock incentive plans (in shares)   126,718    
Stock-based compensation expense 1,407   1,407  
Net (loss) income 54     54
Balance (in shares) at Sep. 30, 2025   22,756,779    
Balance at Sep. 30, 2025 $ 65,821 $ 2 $ 204,470 $ (138,651)